[Oral anticoagulation : Current overview and perioperative management in ophthalmic surgery].

Orale Antikoagulation : Aktuelle Übersicht und perioperatives Management in der Ophthalmochirurgie.
Management Non-vitamin K antagonist oral anticoagulants Ophthalmic surgery Oral anticoagulants Perioperative bleeding risk Vitamin K antagonists

Journal

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
ISSN: 1433-0423
Titre abrégé: Ophthalmologe
Pays: Germany
ID NLM: 9206148

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 17 5 2018
medline: 26 7 2019
entrez: 17 5 2018
Statut: ppublish

Résumé

Antithrombotic treatment with oral anticoagulants and antiplatelet agents can increase the risk for perioperative bleeding. In contrast to other surgical fields, the optimal perioperative management in ophthalmic surgery has not yet been exactly defined and, thus, is not standardized. In this contribution, we provide an overview of currently available oral anticoagulants and discuss potential strategies for the management of these agents in different ophthalmic surgical procedures.

Identifiants

pubmed: 29766263
doi: 10.1007/s00347-018-0724-y
pii: 10.1007/s00347-018-0724-y
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Review

Langues

ger

Pagination

144-151

Références

Br J Anaesth. 2000 Nov;85(5):708-11
pubmed: 11094585
Ophthalmology. 2003 Sep;110(9):1784-8
pubmed: 13129878
Arch Ophthalmol. 2006 Nov;124(11):1558-65
pubmed: 17102002
Am J Ophthalmol. 2007 Sep;144(3):451-3
pubmed: 17765427
Eye (Lond). 2009 Jan;23(1):10-6
pubmed: 18259210
Ophthalmologe. 2010 Jul;107(7):636-40
pubmed: 20024560
Retina. 2010 Oct;30(9):1386-9
pubmed: 20924260
Retina. 2011 Nov;31(10):1983-7
pubmed: 21836531
Clin Exp Ophthalmol. 2013 May-Jun;41(4):387-95
pubmed: 23094982
Br J Haematol. 2013 Oct;163(2):160-7
pubmed: 23937286
Curr Clin Pharmacol. 2014 Feb;9(1):75-83
pubmed: 24218999
Am J Cardiovasc Drugs. 2015 Aug;15(4):235-42
pubmed: 25940651
Cochrane Database Syst Rev. 2015 Jul 02;(7):CD004083
pubmed: 26133124
Curr Cardiol Rev. 2016;12(4):330-335
pubmed: 27146837
Thromb Res. 2016 Aug;144:12-20
pubmed: 27263046
Int J Cardiol. 2016 Oct 1;220:417-28
pubmed: 27390965
Hematol Oncol Clin North Am. 2016 Oct;30(5):1019-34
pubmed: 27637305
Ophthalmologe. 2016 Dec;113(12):1010-1022
pubmed: 27671998
Vasc Health Risk Manag. 2016 Oct 12;12:387-392
pubmed: 27785043
Am J Health Syst Pharm. 2017 Feb 1;74(3):117-129
pubmed: 28122753
Drugs. 2017 Mar;77(3):331-344
pubmed: 28185082
Am J Med. 2017 Aug;130(8):900-906
pubmed: 28390791
Wien Med Wochenschr. 2018 Apr;168(5-6):121-132
pubmed: 28608277
Vasc Health Risk Manag. 2017 Jul 10;13:263-267
pubmed: 28744136

Auteurs

C Sucker (C)

Gerinnungszentrum Berlin Dr. Sucker, Tauentzienstraße 7b/c, 10789, Berlin, Deutschland. sucker@gerinnungszentrum-berlin.de.

A Hager (A)

Gerinnungsambulanz, Charité, Berlin, Deutschland.

J Koscielny (J)

Augenarztpraxis am Elsterplatz, Kissinger Straße 1, 14199, Berlin, Deutschland.

N Feltgen (N)

Augenklinik, Universitätsmedizin Göttingen, Göttingen, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH